+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Dermatological Drugs market set to grow to $34bn by 2022” says Visiongain report

14 August 2018
Pharma

Visiongain’ has launched a new pharma report Dermatological Drugs Market Forecast : Psoriasis, Skin Infection, Acne, Dermatitis, Others

The dermatological drugs market is a specialist segment of the pharmaceutical market which over the last several years has been growing at a faster rate than the overall market. This has been due partly to the high growth potential of biological treatments for psoriasis. The development of new antibacterial drugs to address the problems of population ageing and drug-resistant strains of bacteria will also contribute to the overall market growth.

The lead analyst of the report commented "Visiongain notes that strong growth is expected in the skin structure infections (SSSI) sector of the dermatological drugs market. The increasing number of immunocompromised patients and the ageing population will contribute to the expansion expected in the segment of the market. We also expect growth to be driven by the development of new antibacterial drugs with better safety and efficacy profiles than existing antibiotics."

Leading companies featured in the report include AbbVie, Amgen, Bayer AG, Galderma (Nestle Skin Health S.A.), GlaxoSmithKline (GSK), Johnson & Johnson, LEO Pharma, Merck & Co, Inc., Novartis, Pfizer

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Digital Twin Technology in Pharmaceutical Manufacturing Market

The global Digital Twin Technology in Pharmaceutical Manufacturing market is projected to grow at a CAGR of 31.3% by 2034

23 July 2024

Read

Specialty Pharma Market

The global Specialty Pharma market is projected to grow at a CAGR of 7.5% by 2034

22 July 2024

Read

Synthetic Biology Market

The global Synthetic Biology market is projected to grow at a CAGR of 25.4% by 2034

17 July 2024

Read

Infertility Drugs & Devices Market

The global Infertility Drugs & Devices market is projected to grow at a CAGR of 6.2% by 2034

27 June 2024

Read